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Abstract
The presence of Candida in the gut is normal, but an overproduction may lead 
to serious health problems due to an imbalanced gut, causing gut-related symp-
toms such as bowel movement changes, excessive gas, etc. Some diseases, such as 
Crohn’s disease and ulcerative colitis, are associated with an overgrowth of Candida 
in the gastrointestinal tract. Several recent studies have shown that a prolonged 
candidiasis within the intestines is associated with Candida overgrowth syndrome 
or chronic fatigue syndrome. A healthy digestive system relies on a good balance 
of bacteria that live in the gut, and an important role in maintaining this balance 
is having the ingested type of food. Candida overgrowth can be prevented first of 
all by healthy eating patterns, as susceptibility is increased by a high-sugar diet 
and diabetes or nutritional deficiencies causing a dysregulated immune system. In 
general, Candida-associated conditions have a high impact on performance. Recent 
research has shown an increasing interest in the Candida-related conditions and 
diseases.
Keywords: physiology, gastrointestinal conditions, gut microbiota, elderly, athletes, 
diet therapy
1. Introduction
Everyone has yeasts like Candida spp., mostly Candida albicans, in their intes-
tines, and only seriously ill people will get sick. In contrast, other therapists fear 
life-threatening diseases if these germs are detected [1].
Many patients are completely unsettled. These are very seriously ill patients such 
as cancer or AIDS patients whose defense is extremely weakened [2]. In their cases, 
the internal organs can fail due to a fungal attack. Fungal diseases and intestinal 
mycoses have actually increased in recent years. Gynecologists observe that more 
and more women suffer from vaginal mycoses.
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The reasons for this increase are, for example, nutritional errors such as too 
much sugar and white flour products or nutritional deficiencies causing a dysregu-
lated immune system [3]. However, treatments with cortisone and antibiotics and 
the increase in environmental pollutants are also contributing factors. All of these 
factors weaken our immune system and thus promote the spread of the fungi. If, for 
example, antibiotics have damaged the natural intestinal flora, Candida yeasts can 
spread because important physiological germs are lacking as opponents.
Unfortunately there are only nonspecific symptoms that can have many other 
causes. In the foreground are diarrhea and constipation—often alternating—flatu-
lence, an abdominal distension, and abdominal pain. Affected people reported 
migraines, depression, liver diseases, and skin changes. But symptoms may or may 
not be due to Candida.
When referring to the intestinal yeasts, it is usually of Candida genus. Yeasts can 
be found practically everywhere in nature: they colonize the mucous membranes 
of humans and animals, adhere to objects, and can be found in water and soil. C. 
albicans are commonly found in the intestine. These yeasts were previously found 
in 80% of all intestinal yeast infections. In contrast to other Candida species, C. 
albicans adheres to the mucous membranes of warm-blooded humans and animals. 
Their transmission takes place directly through physical contact. In healthy people, 
however, this is completely unproblematic. But there are also numerous other types 
of Candida that have been on the rise recently. Yeasts find optimal living conditions 
in the intestine as the environment meets their requirements and provides them 
plenty of food [4].
People with weakened immune systems are particularly at risk of contracting 
Candida. Older people (elderly), whose defenses are weakening, are also considered 
a high-risk group [5].
The role of intestinal gut microbiota in health and disease is gaining more 
attention and is increasingly recognized [6]. The philosophy of alimentation might 
give us a clear start to see the patient as a whole again. It cannot only be drugs and 
medicine to treat the diseases [7].
2.  Candida spp. as member of the human gastrointestinal tract 
microbiota
In the normal human gastrointestinal tract microbiota, Candida species are 
part of and can be found in the oropharynx, esophagus, gastrointestinal tract, and 
vagina. When the immune system is compromised from different reasons, a local or 
invasive infection can be developed [5, 8].
Candida species are among the most common yeast, and as fungi in stool 
cultures, the most common germ is C. albicans. C. albicans is one of the optionally 
pathogenic fungi that only trigger a disease under certain conditions [1, 9, 10]. 
However, numerous other types of fungi can also be detected in healthy intestinal 
flora in small numbers of germs using modern methods. With reduced immune 
defense like with HIV disease, but also with diabetes mellitus or cancer and with 
therapies with immune inhibitors (immunosuppressive therapy, e.g., with steroids 
[cortisone]), the amount of Candida in the intestine can increase significantly, so 
that a serious disease becomes possible [2].
Overgrowth of the intestine (over 1,000,000 fungi/g stool) is often accompa-
nied by annoying gas, intestinal cramps, and/or diarrhea. If such symptoms occur 
in patients with a weakened immune system, overgrowth with Candida should also 
be considered [11–13].
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3. Candida hypersensitivity syndrome
Candida hypersensitivity syndrome was first described 20 years ago. For many 
years, C. albicans has been mentioned as the cause of Candida hypersensitivity 
syndrome. This chronic syndrome is also known as chronic candidiasis, Candida-
related complex, and “the yeast connection” [14].
A Candida “infection” or colonization—not proven—is associated with a 
variety of diseases, e.g., cancer, permanent fatigue and exhaustion, depression, and 
headache. In addition, there is always speculation that the irritable bowel may have 
to do with an overgrowth of fungi in the intestine. Still enough scientific evidence is 
lacking [15–17].
Candida is often held responsible for unspecific physical complaints or symp-
toms. As explained above, the simple detection of fungi in the intestinal flora in 
small numbers does not justify the start of a corresponding therapy [18]. Extensive 
and often costly treatment methods such as stool enema, colonic hydrotherapy, 
detoxification, and antifungal diets are particularly special or rejecting self-urine 
therapy as unscientific and unsuccessful [19].
Symptoms such as fatigue general malaise and genitourinary and neuropsychiat-
ric complaints and nonspecific gastrointestinal symptoms are reported.
The syndrome is considered to be caused by vaginal and intestinal fungal 
overgrowth, production of fungal toxins, inflammation, and invasion of mucous 
membranes. In such conditions, the usual therapy will consist of a rigorous long-
term antifungal treatment and “yeast elimination” diet [20–22].
A nutritional imbalance demonstrated by diet analysis could lead to the develop-
ment of further nutritional deficiencies for a prolonged period of time diet [19, 23].
4.  An overview of Candida-related conditions in athletes’ case: impact 
on athlete physiological performance capacity
Exercise has a strong impact in an athlete’s body. In fact, intense exercise, and 
particularly endurance exercise, requires an adaptive regulation of athletes’ body 
in order to fulfill the new physiological and biochemical demands. Under these 
stimuli, the muscle adapts by improving its metabolic, mechanical, contractile, and 
neuromuscular functions [24]. Glycogen storage decreases, mitochondrial biogen-
esis increases, and the balance of electrolytes varies [25]. Moreover, in response to 
the higher demand of oxygen and nutrients by the muscle, cardiac output, ventila-
tion, and gas exchange increase, which finally results in an increased vascular 
dilatation. Exercise increases the risk of dehydration as a result of the increment 
of body temperature. In order to compensate for and reestablish the homeostatic 
equilibrium, the amount of glucocorticoids and adrenaline release should be higher 
[26, 27]. Furthermore, blood flow decreases in the liver, pancreas, and kidneys 
where metabolism activity increases.
Exercise also damages the muscle and highly influences systemic inflam-
mation, intestinal permeability, and an increase in oxidative stress as well as 
immune response, all of them being related with delayed onset muscle soreness 
(DOMS) [28].
DOMS is a muscle pain or discomfort that begins after unaccustomed or high-
intensity exercise [29]. Usually the peak of the pain appears 1–3 days after exercise 
and can last for 5–7 days postexercise [30]. DOMS is recognized as one of the most 
frequent and recurrent forms of sport injury affecting both athletic (including elite 
athletes) and nonathletic population. Its prevalence is higher when exercise activity 
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increases (e.g., beginning of sporting season) or when a new type of activity is 
introduced. Duration and intensity of exercise also influence DOMS. Thereby, 
intense exercise is related to higher degrees of DOMS, immune system suppression, 
inflammation, and oxidative stress, while low-to-moderate exercise is related with 
enhancing the immune system and healthy lifestyle. Despite its high incidence, 
the mechanisms of DOMS remain uncertain, and there are no specific treatment 
strategies. DOMS can negatively affect several factors of athletic performance such 
as muscular pain, reduced joint range of motion, power reduction, altered muscle 
sequencing and recruitment patterns, and muscular strength [29]. Additionally, 
DOMS affects athletic performance by increasing the risk of other muscle injuries 
but also by making athletes more prone to suffer from opportunistic infections 
such as candidiasis. This may be mainly because of the underlying state of chronic 
inflammation due to exercise, altered immune system, and oxidative stress. 
Actually, infectious diseases and particularly fungal infections [31] have been 
identified as the most common and important health problems in athletes [32], 
especially in contact sports. Some studies found that among wrestlers, skin infec-
tions are a common cause of training and match disruption, thus directly affecting 
athletic performance [31]. Also it has been determined that C. albicans, one of the 
most important causative agents of opportunistic infections, was responsible of 
those infections in 5% of the analyzed athletic population [9]. Therefore, it can 
be assumed that the alterations due to the impact of exercise (mainly increase 
of inflammation, affected immune system, and oxidative stress) may alter gut 
microbiota, increasing the risk of opportunistic infections such as Candida infec-
tions. Other studies found that in comparison with controls, athletes used twice as 
frequently oral antibiotics [33]. This supports the hypothesis that specific varia-
tions in gut microbiota may even be the starting point of different diseases develop-
ment [34].
Diet and nutritional or dietary supplements have been identified as the main 
factor affecting gut microbiota (Table 1). In fact, it has been proven that dietetic 
changes can induce up to 57% of gut microbiota [35] variations in terms of com-
position and functioning in 24 hours [36, 37]. On the other hand, several studies 
have demonstrated the influence that gut microbiota have on essential processes 
affecting the individual’s health and performance (e.g., immune response and 
metabolism of nutrients) [34, 38]. Therefore, it could be assumed that diet and 
food supplements (also called nutritional or dietary supplements) may be a critical 
factor through which gut microbiota can be modulated in order to benefit athletes 
in their performance. Actually a recent study has identified several dietetic patterns 
which address this idea [39].
Most studies analyzing the impact of probiotics in athletic performance high-
light their positive impact on the immune function, gut mucosa permeability, and 
oxidative stress resulting from intense exercise but also they increase the risk of 
respiratory diseases that are very common in athletes [40]. Thus, probiotics have 
been proven to improve athletes’ performance.
Up to now, there is no specific information on how diet and food supplements 
directly affect Candida and how Candida further impact athletic performance. 
However, interesting data shown may give a hint regarding Candida behavior 
with respect to probiotic consumption [41]. A study [41] evaluated healthy young 
individuals and analyzed the impact that probiotics consumption has on the pres-
ence of Candida in oral cavity. Results show 46% reduction in Candida prevalence 
after probiotics consumption in oral cavity. C. albicans was the main Candida spp. 
identified followed by C. tropicalis [42].
Finally, evidence supports that also antibiotics influence gut microbiota com-
position. The use of antibiotics increases the risk of opportunistic candidiasis 
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infections. Additionally, it has been also reported that antibiotics may cause fatigue 
and therefore negatively influence athletic performance [41]. Research done to 
analyze the relation between the total use of antibiotics (duration of antibiotic 
courses) and the degree of fatigue has shown that the longer the antibiotic courses, 
the higher the fatigue scores obtained [43, 44].
Lately studies evaluated the ergogenic effect of probiotic supplementation and 
their effect on physical exercises, trying to identify their mechanisms of action and 
on how could they influence the improvement of performance. Due to the fact that 
only few studies were performed and demonstrated the ergogenic effect of probiotics, 
further studies should investigate the subject for better understanding [45–52].
5.  An overview of Candida-related conditions in elderly case: 
physiological alterations
The term “elderly” comprises those individuals aged 60 and older, and they 
represent the fastest growing population group. In fact, in 2017 the global popu-
lation of 60 years old and over totaled 962 million, and it is foreseen to reach 
2.1 billion by 2050 [53]. Already by 2030 it is anticipated that nearly 35% of the 
European population will be over 60 and 11% over 80 years [53]. With age progres-
sion, deficiencies of physiological functions occur, making elderly more vulnerable 
to diseases and infections, particularly from fungal species [54]. Genus Candida 




A fatigue reduction and an improved performance and 
mood can be achieved during an intense training by 
consuming high doses of carbohydrates ad libitum
Proteins 1.2–1.6 g/kg/day (elite 
athletes)
The infection incidents increase due to a protein 
deficiency by decreasing the T cell functions which 
affect the immunity system
Fat 15–30% of the diet/day A reduction of the intestinal inflammation, bacterial 
translocation, and gastrointestinal stress can be 
achieved by fat diets with good amount of omega-3 and 
omega-6




Lower level gut microbiota is associated with low-fiber 
diet and low antipathogenic bacteria and therefore will 
be an increase in gut inflammation and less sympathetic 
nervous system stimulation
However, gastrointestinal stress may be caused by a 
high-fiber diet
Probiotics Highly variable 
depending on the strain, 
microbial composition, 
and metagenome
Because of gut 
microbiota diversity in 
humans, there was not 
established a standard 
dose
Supplementing the diet with fermented food can 
stimulate the expansion of microorganism like 
Bifidobacteria (B.) and Lactobacillus (L.) that have 
beneficial metabolic functions. For example, improving 
short-chain fatty acids results in an increasing immune 
and barrier functions
Table 1. 
Dietary modifications for the improvement of gut microbiota [39].
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especially immunocompromised patients and elderly people and the major caus-
ative agent of nosocomial infections [55]. The step from Candida colonization to 
subsequent infection is not yet clear. However it has been proven that the natural 
flora which develops within the gastrointestinal tract can represent the main source 
in the development of severe infections.
Candida infections are very difficult to diagnose in the elderly and have a 
complicated therapeutic management [56]. Signs and symptoms are often nonspe-
cific and can vary depending on the area affected. Thus, diagnosis depends on the 
clinical evaluation supported by biochemical and microbiological analysis. Given 
the difficulty of diagnosing Candida infection, efforts have been focused on the 
development of new strategies and diagnosis methods such as new culture meth-
ods with increased sensitivity. Also novel antigen-based tests are available for the 
detection of mannan levels which is the main component of Candida cell wall and 
1,3-β-D-glucan which is mainly used in critically ill patients as it has high sensitivity 
[54, 57]. Finally, real-time polymerase chain reaction technique is also applied for 
the detection of five different Candida spp. [54].
Regarding the epidemiology, 90% of all Candida infections are caused by C. 
krusei, C. glabrata, C. albicans, C. tropicalis, and C. parapsilosis [58].
Aging-related physiological changes and other factors frequently affecting the 
elderly such as comorbidities, polypharmacy, and high colonization rate result in an 
extremely high mortality rate (from 36 to 63%) [59].
The oral cavity is considered a major physiological importance and experiences 
numerous alterations with aging process. The impaired functioning of the salivary 
gland alters the quality and quantity of saliva (hyposalivation). This impacts the 
equilibrium of the resident oral microbiota and also results in the decrease of defen-
sive proteins (such as salivary peroxidases or myeloperoxidase) as well as other sub-
stances with antimicrobial activity (e.g., lysozymes), facilitating the development of 
oral candidiasis. Using removable dental prostheses and their deficient hygienization 
also contribute to oral candidiasis. C. albicans followed by C. glabrata and C. tropica-
lis have been identified as the most prevalent Candida spp. found in dental prostheses 
[60]. The use of drugs that irritate or damage the oral mucosa, such as long-term 
antibiotic intake, as well as the presence of chronic and/or concurrent diseases may 
also lead to candidiasis. As already mentioned, Candida colonization can lead to 
severe infections. Thus, from oral cavity colonization, Candida may increase the 
colonization index and reach easier other areas such as the respiratory system [61].
Further, oral candidiasis may lead to appetite decline, and this can limit the 
nutrient intake which can directly influence gut microbiota growth. Appetite 
decline can also be a consequence of other age-related physiological alterations 
(Table 2) [62]. The impaired masticatory efficiency produced by poor dental health 
and related pain, loss of teeth and muscle bulk, and lower sensitivity (includ-
ing taste, smell, and sight) have a negative influence on appetite as food remains 
uninteresting [62, 63]. Oropharyngeal and esophageal motility diminished the 
risk of swallowing impairments (e.g., dysphagia) and prevalence of gastroesopha-
geal reflux. Additionally, alterations in the secretion and peripheral action of 
the hormones that regulate the wish to eat, hunger, and satiation can also reduce 
appetite. Besides the reduction of appetite, the nutritional status of the elderly can 
be influenced by the changes in gastrointestinal motility which can lead to reduced 
digestion and absorption, among others. All those result in the changes in the 
availability of nutrients in the gut which influence the abundance of Candida and 
may lead to dysbiosis. For example, it has been proven that a high-fat diet stimu-
lated the increase in Firmicutes and Proteobacteria and a decrease in Bacteroidetes 
[64]. Poor nutrition has been also proven to be associated with the development of 
inflammatory pathologies (e.g. Crohn’s disease) and chronic disease associated with 
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nutritional status (e.g., diabetes mellitus and cardiovascular diseases). Finally, poor 
nutrition can also derive in malnutrition which is one of the key factors influencing 
the growth of gut microbiota and, thus, may also lead to the dysregulation of the 
immune system and posterior infection.
The immune system is also affected with aging (a process known as immunose-
nescence) [65]. Hence, there have been identified several altered immune parame-
ters as well as adaptive and innate immunity influencing the development of chronic 
inflammatory status. Also the composition of gut microbiota varies with aging [66]. 
It decreases the number and variety of many protective commensal anaerobes such 
as lactobacilli and bifidobacteria. Beside this, phagocytosis is altered as a conse-
quence of the functional insufficiency of monocytes and macrophages. On the other 
hand, “altersinvolution” (referring to age-related involution of the thymus) leads 
in a decline in circulating antigen-presenting cells (e.g., dendritic and T cells) [67]; 
T cells show altered cytokine production and lose their memory capacity as well 
as decrease the number of circulating B cells. Consequently, the immune system 
is compromised, and thus, there is a higher risk for the elderly to develop serious 
fungal infections, especially disseminated candidiasis. The source of this infection is 
often the gastrointestinal tract. The administration of broad-spectrum antimicrobial 
agents to these patients increases their risk of Candida infections by increasing the 
frequency and magnitude of gastrointestinal tract colonization by Candida spp.
Physiological changes associated with aging also affect the metabolism of many 
drugs [68]. As time passes, the hepatic capacity diminishes, affecting drug clear-
ance. Specifically, the microsomal cytochrome P450-dependent monooxygenase 
system is altered, and therefore, the drugs that undergo this pathway cannot be 
cleaned properly. Liver volume and blood flow also decline, impacting drug clear-
ance. In addition renal size and volume are reduced. There are less glomeruli and 
juxtamedullary nephrons, resulting in a decrease in filtration area of the glomerular 
basement membrane and decreased permeability. Thus, the glomerular filtration 
rate (GFR) is decreased [69]. Both liver and renal modifications impact the elderly’s 
pharmacokinetics and pharmacodynamics variables, thus making them at higher 
risk of adverse drug reactions and harmful drug interactions. Together with the 
above information, other common factors such as serious underlying diseases 
and comorbidities, the use of antibiotics and immunosuppressive drugs, living in 
care facilities, or being hospitalized increase the risk of the elderly suffering from 
Candida-induced infections (particularly Candida oral infections) and make them 
more vulnerable.
Natural aging physiological alterations
Alterations in oral cavity (e.g. hyposalivation and impaired masticatory efficiency)
Alterations in the secretion and peripheral action of the hormones that regulate the wish to eat, hunger, and 
satiation
Changes in gastrointestinal motility
Immunosenescence (alterations in immune system such as decreased phagocytosis and age-related involution 
of the thymus or altersinvolution)
Changes in gut microbiota




Natural aging physiological alterations.
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For frail elderly, severe surgeries, the use of central venous catheter, and 
parenteral nutrition are associated with candidemia related to biofilm formation 
and hence persistent colonization and infections [70]. Biofilm formation by an 
irreversible adhesion of a community of microorganisms which attached to each 
other on a surface, inert material, or living tissue, produce extracellular polymers 
that provide a structural matrix. The microorganism in this community behaves 
differently, showing more resistance to antibiotics and lower growth rates. 
Different Candida spp. have been identified to be implicated in biofilm formation. 
Each of them exhibits particularities in terms of biofilm formations (morphology, 
extracellular matrix, antifungal resistance, etc.) and thus complicating treatment. 
C. parapsilosis has been characterized as the most frequently causative agent of 
catheter-related infections through biofilm formation [71]. It is an exogenous 
pathogen found mostly on the skin of healthy hosts which easily spread through 
hand contamination in hospitals and care facilities. C. tropicalis is particularly 
relevant in urinary tract infections [72, 73].
6. Candida elimination diet therapy
An important point is the amount of fungi found in the intestine. Antibiotic 
treatments are damaging the natural intestinal flora, and fungi such as Candida 
spread because important physiological germs are lacking as opponents [74]. 
Treatments such as antibody therapies or enteral nutrition can reduce the inflam-
mation, and gut microbiota is improved.
A dietary formula for 1 week lacking fiber reduced the populations of fungi [75]. 
Therefore, it is believed that the gastrointestinal environment can be restored by a 
proper defined nutrition diet formula [76–78].
Such diets are high in sugar and total carbohydrates which are correlated with 
increased methanogen Methanobrevibacter and fungus Candida and other genera 
from different domains of life that are negatively associated with the consumption 
of fatty acids, protein, and amino acids [79].
Candida is the predominant fungal species capable of colonizing the gut and can 
vary extensively in time in response to recent carbohydrate consumption, antibiotic 
use, and environmental sources. Bacterial population structure primarily associ-
ates with long-term diet [80]. In a recent study, Candida correlated positively with 
long-term intake of total carbohydrates and sugar and had a strong association with 
recent carbohydrate intake.
Short-chain fatty acids (SCFAs) have been shown to exert fungistatic effect. 
Anaerobic intestinal microbiota, such as lactic acid bacteria (LAB) as a member of 
normal flora, produces from dietary fibers via fermentation of beneficial metabo-
lites, and the major end products are SCFAs. Not only for the intestinal microbiota, 
SCFAs represent an energy substrate but for host cells as well. Their important role 
in reducing the development of gastrointestinal disorders, among others, is well-
known, preventing overgrowth of Candida [81].
The probiotic strain L. rhamnosus GG offers benefit human health, and is a 
commonly used probiotic strain with immunomodulatory effect and bears an 
exopolysaccharide interfering with Candida growth and invasion tested in a model 
of gastrointestinal candidiasis, mostly attributed to C. albicans [82]. SCFAs have 
an effect on morphogenesis and therefore may provide a mechanism by which 
LAB could prevent candidal colonization. The growth rates are crucial for fungal 
growth in medium containing the disaccharide maltose as a sole nutrient source 
[74, 81].
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In a clinical study performed in individuals with chronic intestinal Candida 
overgrowth receiving nystatin alone and following a diet therapy (avoiding foods 
high in simple sugars and starch), different cured rates have been achieved during 
the 3 months of tests, 42% compared to 85% [21].
The yeasts metabolize a part of the carbohydrates from food, producing carbon 
dioxide and fusel alcohols. The gas causes an abdominal distension, bloating, 
and abdominal pain. Prolonged exposure to fusel alcohols for weeks and months 
can damage the liver. It was only this spring that a special toxin produced by the 
Candida yeast was found, which is responsible for many of the effects on other parts 
of the body. There is still a lot of research to be done in this area.
Most of the usual antifungal diets are based on the elimination of sugar and 
other carbohydrates and can actually relieve bloating and other irritable bowel 
symptoms in some patients (with or without fungal overgrowth) [83, 84]. 
Practitioners of alternative medicine often claim that candidiasis—the most com-
mon cause of yeast infections (vaginal candidiasis) and oral thrush (oral candidia-
sis)—can be treated or prevented with diet and food supplements [11]. Despite a 
lack of clinical evidence, Candida diets have become incredibly popular in recent 
years, mostly among women with recurrent yeast infections.
The effect is probably based on a combination of different changes at the level of 
bacterial flora, the formation and transport mechanisms of intestinal gas, and the 
osmotic properties of the intestinal contents. The concept of the Candida diet is that 
Candida uses sugar compounds (carbohydrates) to extract energy from them. If 
these sugar compounds are no longer available through the diet, the Candida can be 
“starved” in this way [85].
The Candida yeasts break down carbohydrates from food into carbon dioxide 
and fusel alcohols. The gas causes a bloated stomach, a feeling of fullness, and pain 
in the intestinal area. If the exposure to fusel alcohols lasts longer, they can damage 
the liver. The Candida yeast produces a special toxin that has only recently been 
identified and can trigger symptoms such as migraines or joint illnesses [86].
A consistent antifungal diet of at least 5–6 weeks is also essential. It is important 
to deprive the yeast of their base food. Sugar, sweets, white flour products, and 
alcohol should be strictly avoided. Sweet fruit should also be avoided in the first 
4 weeks. The focus is on a wholesome diet with lots of lettuce, vegetables, and 
whole grain products. The high-fiber diet not only strengthens the immune system 
but also presumably exerts a mechanical cleaning effect by sweeping the fungal 
nests out of the villi through its fibrous structure and at the same time stimulating 
the bowel movement [87, 88]. High-content phytochemicals with an antimicrobial 
effect make the whole-food diet the ideal antifungal diet—however, success is only 
permanent if there is a consequent change in diet.
Whole foods are the best way to prevent yeast infections. The yeasts will not find 
the right breeding ground in the organism of a healthy person. If there is already 
an infection, targeted therapy and a long-term change in eating habits to a healthy, 
natural diet are effective remedies.
In microbiological therapy, the focus is on strengthening the immune system 
[89]. Bacteria are extremely important for an intact immune system. An estimated 
100 trillion bacteria live in the intestine, many of which are not yet known. It is 
now known that these bacteria have important functions for the immune system 
and are not simply there by accident. Experience after lengthy antibiotic admin-
istration speaks about, again and again, weaknesses in the body’s defenses which 
are observed because these active ingredients not only destroy unwanted but also 
desired bacteria. In our environment, which is enlivened by countless germs, the 
animals die of fatal infections after a few days because their defense system is 
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practically inadequate. The contact with bacteria is very important for the develop-
ment of the immune system. This effect is mimicked with microbiological therapy. 
The patients are given probiotics and auto-vaccines for 3–6 months. Probiotics 
are preparations from intestinal germs that regulate the immune system. Several 
studies suggested that certain Lactobacillus probiotic strains enhance the effect of 
antifungal drugs (like fluconazole) used to treat yeast infections. However, there 
was no evidence that the strains could achieve the same effect on their own [90–95].
The use of probiotics in treating yeast infections is controversial. Although 
probiotics work by increasing bacteria beneficial to the vagina and gastrointestinal 
tract, their ability to prevent or treat candidiasis is a subject to debate. While many 
studies suggest that a daily probiotic can “slightly improve” imbalances that lead to 
yeast infections, others do not [96].
With these foods too, some of the bacteria will certainly live in the intestine. 
It is probably not possible to permanently colonize these bacteria in the intestine. 
However, a distinction must be made between probiotic medication and food. Special 
foods, such as yogurt preparations, cannot be used to inject as many bacteria as with 
medication. Patients would have to eat tons of yogurts in order to achieve a therapeu-
tically effective number of bacteria. Then, however, they would have problems with 
the masses of animal protein again.
To permanently eliminate the yeast, a change in eating habits is crucial. The 
yeast must be deprived of their food base. It is very important to avoid sugar. In the 
acute diet phase of 4 weeks, patients even have to do without sweet fruits because 
Candida can also utilize fructose. Only sour apples, lemons, and grapefruit are 
allowed. The focus is on a high-fiber diet, which means a lot of salad and veg-
etables as well as whole grains [97, 98]. Their fiber exerts a mechanical “cleaning 
effect” by sweeping out the fungal nests between the villi, and they stimulate the 
movement of the intestine. In addition, fiber is cheap because it cannot be broken 
down by the yeast in the intestine. We therefore recommend our patients to eat 
whole foods.
The complex carbohydrates and especially the fiber are digested in the lower 
intestinal sections. However, the yeasts mainly colonize the upper sections because 
they require oxygen. Only relatively few yeasts can survive in the colon. Only an 
insignificant part of the yeast uses the complex carbohydrates and fiber [99].
The die-off effects (Candida dies) can be strong, especially at the beginning 
of treatment when a large amount of Candida fungi dies at once. Likely massive 
adrenal fatigue can be experienced during this period. In this case, the recommen-
dation is to take a couple of weeks off not to add any new foods to diet. Die-off is 
usually a problem from the beginning to about the middle of treatment. As healing 
progresses, the die-off symptoms (like the other Candida symptoms) will occur less 
frequently and at greater intervals. Therefore, at the same time with the diet, it is 
highly recommended to start with antifungals and probiotics. The combination of 
these two kills the Candida yeast in the intestine and immediately populates it with 
“good bacteria.”
An antifungal diet always represents an individual nutritional concept, which in 
general is based on the results of laboratory analysis. In the case of a stronger fungal 
attack, an antifungal medication is recommended. The microbiological therapy is 
often useful, since the intestinal flora is usually affected; otherwise the fungi would 
not have been able to multiply.
Candidiasis affecting the whole organism is fatal in about 70% of cases. The 
problem is Candida-induced sepsis, in which the pathogens can be found in large 
numbers in the blood. Around 40,000 people in Germany are affected by this 
invasive Candida infection every year. When it comes to hospital infections, it 
represents number 4 on the list of the most dangerous pathogens [100].
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7. Conclusions
Numerous microorganisms live in our intestines, especially Candida. As long as 
the intestinal flora is in natural balance, Candida does not cause problems.
In people whose immune systems are weakened by disease or medication—the 
elderly population, C. albicans can also cause inflammation. The problem is that a 
Candida infection is often diagnosed late because of its diverse symptoms.
The Candida diet is believed to limit Candida colonization and thus prevent 
such opportunistic infections. The Candida diet’s aim and scope are boosting the 
immunity, reducing inflammation, and improving gut health. The diet is based on 
removing added sugars, focusing on consumption of fermented foods, and avoid-
ing pro-inflammatory triggers. By providing an optimal nutrition, a reduction of 
inflammation and depriving C. albicans will be possible. Antifungal diet is believed 
to greatly reduce the number of microorganisms in the intestine within at least 
4 weeks.
Nevertheless, it is recommended to carry out the diet under medical supervi-
sion, especially if there are problems with the intestinal flora.
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